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Background: Attrition is an important problem in cohort studies. Tracing cohort members who have moved or
otherwise lost contact with the study is vital. There is some debate about the acceptability and relative effectiveness
of opt-in versus opt-out methods of contacting cohort members to re-engage them in this context. We conducted a
randomised controlled trial to compare the two approaches in terms of effectiveness (tracing to confirm address and
consenting to continue in the study), cost-effectiveness and acceptability.
Methods: Participants in this trial were individuals (young people and mothers) recruited to the Avon Longitudinal Study
of Parents and Children (ALSPAC), who had not engaged with the study in the previous 5 years and for whom mail had
been returned from their last known address. The sampling frame was restricted to those for whom database searching
led to a potential new address being found in the Bristol area. 300 participants were randomly selected and assigned
using stratified randomisation to the opt-in or opt-out arm. A tailored letter was sent to the potential new address, either
asking participants to opt in to a home visit, or giving them the option to opt out of a home visit. Fieldworkers from Ipsos
MORI conducted home visits to confirm address details.
Results: The proportion who were traced was higher in the opt-out arm (77/150 = 51 %) than the opt-in arm
(6/150 = 4 %), as was the proportion who consented to continue in ALSPAC (46/150 = 31 % v 4/150 = 3 %). The
mean cost per participant was £8.14 in the opt-in arm and £71.93 in the opt-out arm. There was no evidence of a
difference in acceptability between the opt-in and opt-out approaches.
Conclusion: Since the opt-in approach yielded very low response rates, and there were no differences in terms of
acceptability, we conclude that the opt-out approach is the most effective method of tracing disengaged study
members. The gains made in contacting participants must be weighed against the increase in cost using this
methodology.
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It is well recognised that one of the greatest challenges of a
cohort study is to maintain representativeness, and preci-
sion of estimates, by minimizing attrition [1]. In many stud-
ies, participants lost to follow-up are different from those
who continue to take part in terms of socio-economic vari-
ables [2]. This is borne out in analyses of participation in
the Avon Longitudinal Study of Parents and Children
(ALSPAC) [3, 4], birth cohorts in different settings [5], and
younger birth cohorts [6, 7]. Studies which rely on paper
questionnaires for data collection are particularly suscep-
tible to these biases [8]. Loss to follow up may also be asso-
ciated with poorer health outcomes [9] and the resulting
biases may lead to under-estimation of health inequalities
[10, 11] and a tendency towards null findings [12], though
this is not always found to be the case [13].
Participants become lost to follow-up for several rea-
sons – failure to locate, failure to contact, or refusal to
take part [14]. This paper is concerned with the first of
these, which may in part be associated with increasing resi-
dential mobility [1]. Approaches to ‘Tracking and Tracing’
(the task of maintaining up-to-date address data for a co-
hort) have been summarised [15, 16], and the success of
methods used by existing studies assessed [17]. Although
there has been a recent trend to evaluate the effectiveness
of certain tracing procedures, such as between-wave mail-
ings [17–20], relatively few cohort studies formally evaluate
the cost-effectiveness of such activities [21], or the accept-
ability of these methods to participants.
The importance of establishing current addresses prior to
a data collection exercise is emphasized by Calderwood
(2010) [17]. Child cohort studies with a social science focus
commonly collect data through home visits, and therefore
routinely use face-to-face field tracking methods to update
address information. Studies with a more biomedical focus,
like ALSPAC, tend to use questionnaires and clinics for
data collection, but face-to-face tracking could still be cost-
effective for local area studies, such as ALSPAC, even if
they do not use this method for data collection [21]. During
September 2012 (two years after the last paper question-
naire data collection exercise), office-based tracking was
used to search for current addresses for lost participants in
ALSPAC. This coincided with the 2012 questionnaire to
YPs, then aged approximately 21 years. For those classed as
‘disengaged’ (no participation for at least 5 years), a home
visit rather than a phone call was decided to be the most
appropriate method of confirming the address with the par-
ticipant. We felt that an opt-out approach to the home visit,
as commonly used in longitudinal studies with a social sci-
ence focus, would be more successful than an opt-in
approach. However, there has been much debate around
the ethics of opt-in and opt-out in the bioethics and epi-
demiology literature, and it is less commonly used in bio-
medical cohort studies. There is some evidence thatexpecting participants to opt-in to epidemiological research
can result in bias and a less representative sample [22]; opt-
out consent may improve response rates [23, 24], thereby
reducing bias, but remains controversial in the biomedical
field [25]. There is limited published evidence on the topic,
but a randomised trial of the two methods for recruiting
patients to medical research [26] concluded that where risk
is low to participants, then the opt-out approach results in
higher response rates and a less biased sample. Tradition-
ally, opt-in consents have been considered more respectful
of autonomy (as only those who expressed an interest
would be involved). For the purposes of data collection, this
could save time and money, reduce harm and possibly in-
crease rates of re-engagement. There is little evidence about
the relative merits of the opt-in versus opt-out approaches
for home visits for the purposes of tracing lost participants
in a prospective cohort study. The ALSPAC Ethics and
Law Committee, who have a remit to balance the represen-
tativeness of the cohort against over-intrusive research,
took a cautious view on opt-out home visits (both from the
point of view of participants and neighbours who might be
contacted as part of the tracing process), and required evi-
dence of the relative benefits and harms before allowing the
routine use of opt-out home visits. The purpose of the Ran-
domised Controlled Trial (RCT) described in this paper is
therefore to compare the effectiveness, cost-effectiveness
and acceptability of an opt-out versus opt-in approach to
home visits for confirming addresses with participants in
ALSPAC. The results will be of interest to other biomedical
cohort studies that do not routinely use face-to-face track-
ing methods, and the findings regarding cost-effectiveness
and acceptability are relevant to other cohort studies more
broadly.
Methods
The ALSPAC study
ALSPAC is a prospective cohort study investigating influ-
ences on health and development across the life course. It
is known to participants as ‘Children of the 90s’ (ALSPAC).
The eligible cohort comprises the families of women preg-
nant while living in and around the City of Bristol with an
estimated delivery date between 01/04/91 and 31/12/92.
Seventy-two percent (14,541/20,248) of eligible mothers
were recruited antenatally. The enrolled sample consists of
14,776 children, now referred to as Young People (YP),
representing 75.4 % of 19,600 eligible livebirths from the
15,247 pregnancies where an individual (mother, primary
carer or child) has provided data. Further details about the
enrolled sample and response rates are published in the co-
hort profiles of the mothers [4] and YPs [3].
Data collection in the ALSPAC study is through ques-
tionnaires and clinics (please note that the study website
contains details of all the data that is available through a
fully searchable data dictionary [27]). Response rates to
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the YPs it is likely that failure to locate, through out-of-
date addresses, is a significant factor - at around 21 years
of age they are highly mobile and many will have left the
family home or be temporarily away from home, either
at university or travelling. The length of time between
data collection exercises in cohort studies such as
ALSPAC also has a negative impact on keeping track of
participants (3 years between the most recent two ques-
tionnaires for YPs, 2 years for mothers). Between-wave
mailings such as newsletters, birthday and Christmas
cards are used as a way of keeping in touch with partici-
pants. For 8 % of YPs in the study, we believe that the
address data held by Arcadia, our administrative data-
base, is out-of-date because mail has been returned to us
(these participants are referred to as ‘lost’). The mothers
in the study have more stable addresses, and the propor-
tion known to be lost is lower, at 5 %.
Participants
Mothers and YPs were eligible to be included in the trial if
they were both ‘lost’ (we have received returned mail from
their last known address) and ‘disengaged’ (had not partic-
ipated in the last 5 years) having previously enrolled and
participated in ALSPAC. Certain groups of participants
were excluded - twins, those who had withdrawn, and
those in the safeguard group (these are participants whom
the study ‘Participation Team’ deem should not be con-
tacted due to current family circumstances). This left
1,283 eligible participants.
Address searching
ALSPAC has linked participant records to their contact
information using the NHS demographic database; a
process facilitated by the NHS Health and Social Care
Information Centre. Publicly-available databases (192.com
and AFD) were also used for office-based tracking.
192.com and AFD are online directories that provide up
to date address and contact information on members of
the public for a fee. The information provided by these
directories is obtained through publicly-available data
from the Directory Enquiry database, the Electoral Regis-
ter and the Database of Company Directors. The director-
ies are updated approximately every four months. They
were used to search for a new address for ‘lost’ partici-
pants. These were compared within ALSPAC by the GP-
registered address provided by the NHS. Where two out
of these three sources agreed, we recorded this as a likely
new address (although in some cases this address matched
the last known address for the participant). There were
551 participants (mothers or YPs) who fulfilled this cri-
teria. For the purposes of this trial, these were then re-
stricted to those for whom the new address was in the
Bristol area (a BS postcode), leaving 412 participants withaddresses within the boundaries of the original study
catchment area.
Ethics
The use of office-based tracking to find addresses, the RCT
to compare opt-in and opt-out approaches to home visits,
and the use of an external company to carry out the home
visits were all approved by the ALSPAC Ethics and Law
Committee (reference E201203, approved 19/10/12). The
committee requested that the acceptability of contacting
neighbours and other community members was reviewed
after the first 20 approaches.
The use of NHS contact data was approved by the NHS
Patient Information Advisory Committee (PIAG reference
NHR 107/027/99, approved 16/08/05), now the Health
Research Authority Confidentiality Advisory Group. This
approval allows ALSPAC to use NHS contact information
to trace study participants. The patient information mate-
rials used to describe study enrolment and consent for
record linkage were approved by an NHS Research Ethics
Committee (Haydock REC reference 10/H1010/70, ap-
proved 03/02/11).
Sample size calculations
Sample size calculations were based on the assumption
that 10 % of those in the opt-in group would respond
positively. This estimate came from the response rate to
a pilot mailing for consent to data linkage which was
sent to the YPs in 2011. An absolute difference of 12 %
between the opt-in and opt-out arms has been suggested
[18]. Therefore, 150 participants in each arm would re-
sult in 80 % power to detect a difference between a
10 % response rate in one arm of the trial and <1.5 %
or >22.5 % response rate in the other arm.
Stratification
From the 412 traced participants in the Bristol area we
randomly selected 300 participants for the RCT, stratified
according to three variables: (i) mother or YP, (ii) gender
(for the YPs), and (iii) maternal education (low:none/voca-
tional; high:O’level/A’level/degree). (Those with missing
maternal education were randomly assigned to one of the
maternal education groups.) The number of eligible
participants and the number randomly selected are
shown in Table 1. The selected sample comprised 120
mothers and 180 YPs. The sampling was conducted
using the runiform () function in Stata 12 [28].
The RCT
Participants within each of the strata shown in Table 1
were randomly assigned to the opt-in group (Arm 1) or
the opt-out group (Arm 2) by the study analyst, again
using runiform () in Stata, ensuring that characteristics
such as mother/YP status, gender (for YPs only) and
Table 1 Stratified sample for RCT
Strata Mother/YP Gender Education Eligible
participantsa
Number
in trial
1 Mother - Low 100 60
2 Mother - High 117 60
3 YP M Low 52 50
4 YP F Low 40 40
5 YP M High 61 50
6 YP F High 42 40
afor whom we have found a ‘likely’ address in the Bristol area
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of the trial. The lists of participants in each arm of the
trial was sent to Ipsos MORI. Participants in both arms
then received a letter from an Ipsos MORI fieldworker,
explaining that the recipient was once part of the
ALSPAC study, and the importance of both the study
and the individual’s participation. The letter had the
usual 'Children of the 90s’ branding as well as Ipsos
MORI branding. The opt-in letter invited the participant
to make an appointment with the fieldworker for a
home visit – only participants that responded positively
were to be visited. The opt-out letter gave the partici-
pant the opportunity to make an appointment at their
convenience, or to opt-out of the visit – otherwise the
fieldworker would attempt to visit the address without
an appointment. Participants were given 15 days to re-
spond. Home visits took place between 3 and 8 weeks
after the initial letter was sent. No monetary incentive to
encourage participation was offered.
The primary purpose of the RCT was to compare the
effectiveness, cost-effectiveness and acceptability of an
opt-in versus opt-out approach to home visits to locate
the lost participant and to gain their consent to continue
to be an ALSPAC participant (allowing us to store their
updated contact details on our database). Since those in
the opt-out arm who were not found to be at the address
given were then traced by the fieldworker, the interven-
tion we were testing included both tracing and a home
visit. The opt-in arm, by contrast, did not require tracing
if they opted-in, but those who did not opt-in received
neither home visit nor tracing. A secondary purpose was
to provide the YPs who received a home visit with infor-
mation about ‘data linkage’ to routine records, with the
ultimate aim of gaining consent for data linkage. The
routine sources of data listed were health records, edu-
cation records (from school, further education and
higher education), benefits and earnings records, and re-
cords of criminal convictions and cautions.
Finally, the acceptability of the opt-in and opt-out
home visits was assessed by asking participants directly
what they thought of the opt-in/opt-out approach, and
using feedback from the interviewers. Interviewers alsoprovided feedback on the acceptability of contacting
neighbours and other community members part way
through the fieldwork, for approval by the ALSPAC Eth-
ics and Law Committee.The home visit
The home visits were carried out by the independent re-
search organisation, Ipsos MORI. Although it was neces-
sary for fieldworkers to be aware of whether participants
were in the opt-in or opt-out arm, the home visits were
conducted in exactly the same way for participants in both
arms of the trial. Fieldworkers introduced themselves as
from Ipsos MORI, representing the University of Bristol
(to protect the anonymity of participants, ALSPAC was
only mentioned once it had been established that the
fieldworker was speaking with a participant). The four
fieldworkers carrying out the home visits were trained to
provide the participants with background information
about ALSPAC, and had printed materials to share with
the participants. They had a participation history for each
participant, to allow them to tailor the conversation ap-
propriately (this included date of last clinic/questionnaire
completed, whether the participant was currently re-
corded on our database as having opted out of question-
naire or clinic invitation mailings, and a percentage score
indicating previous level of participation in ALSPAC).
Initially the interviewer confirmed that the individual
(s) had previously enrolled into the study and then de-
termined if they had capacity to consent. Where this was
the case, mothers were reminded about the history of
the study and were asked to provide a broad consent
that would enable ALSPAC to retain their contact details
on the study database and invite them to participate in
data collection exercises in the future. Study YPs, whose
previous participation had taken place as a minor under
the consent of their parent/carer, were asked to enrol
into the study in their own right. Enrolment in this con-
text meant to consent for their contact details to be
maintained on the study database and allow ALSPAC to
invite them to participate in future data collection. Inter-
viewers provided the YP with a study information pack,
describing general participation in the study and a re-
quest to consent for the study’s use of their health and
administrative records as a means of retrospective and
prospective follow-up. Interviewers were instructed only
to discuss this additional consent if they judged that the
YP was happy to do so, and that it would not comprom-
ise their agreement to participate overall. Otherwise the
YP could respond at a later date using a reply-paid enve-
lope contained in the information pack. Where consent
for data linkage was discussed, the YP had the option to
ask questions. The consent form provided the opportun-
ity for the YP to give consent/refuse to the use of each
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of bio-samples or questionnaires took place.
Tracing participants
When the home visit was not initially successful in mak-
ing contact with the participant, the fieldworker attempted
to trace them using a range of tracking techniques com-
mon in longitudinal studies [18, 29]. The key tracing steps
are outlined in Additional file 1: Table S1. All tracing at-
tempts were recorded. Interviewers were required to make
contact with the participant using the new address found
through address searching, and were required to make a
minimum of six calls at this address (ensuring that at least
half of these were at a weekend or during the evening) be-
fore coding a final outcome. All initial contact was speci-
fied as face-to-face, but if interviewers had not managed
to make contact after four face-to-face visits or if they
established that the named participant had moved, then
they could use any of the telephone numbers provided
and begin tracing procedures. In-field tracing procedures
included speaking to neighbours and community mem-
bers. Interviewers were required to pursue tracing if they
found the participant was no longer at the address or if
they failed to establish contact after four face-to-face visits
and after using all home and mobile telephone numbers
provided.
Statistical analysis
Data on visits to each participant with whom a home
visit was attempted were recorded on a contact sheet
and compiled in a spreadsheet. The main outcome of
interest for this study was consent for ALSPAC to store
contact details (for continued participation in ALSPAC).
Other variables available included the information pro-
vided to the fieldworkers on participation history (vari-
ables described above), the number of visits or phone
calls made to each participant, whether neighbours were
contacted (and their attitude towards being contacted),
and finally whether the participant consented to con-
tinue in ALSPAC. These variables were tabulated by trial
arm in Stata [28], and differences between arms were
assessed using Fisher exact tests. This analysis was car-
ried out on an intention-to-treat basis. Those who con-
sented were compared with those who did not, in terms
of key variables.
Fieldworker time for attempted and actual visits, phone
calls, other contacts and their travel expenses for each visit
was assumed to be the same in both arms of the trial. Unit
costs for these resources were calculated as the total costs
of these items divided by the total number of events
(e.g. number of home visits) in the study. The actual
(non-staff ) cost of the phone call was not included in
the analysis as monthly costs for telephone contracts
do not depend on the number of actual calls. Costswhich applied equally between both arms of the trial,
such as the initial setting up of the project, were ex-
cluded from the analysis. The mean resource use per
participant for each item of resource use by trial arm
was calculated by dividing the number of events by the
number of participants within each trial arm. The mean
resource use was multiplied by the unit cost to obtain
the mean cost per participant. The total mean cost per
participant by arm of trial was calculated by summing
the resource specific mean costs. The total cost by arm
of trial was estimated by multiplying the total mean
cost by the number of participants within each arm.
The difference in total mean cost and total cost was
compared with the difference in the number of partici-
pants consented between the two arms and, finally, an
incremental cost-effectiveness ratio (the difference in
total costs divided by the difference in number of par-
ticipants consented) was calculated.Results
Outcomes in each arm
For the majority of the 300 participants selected into
the trial, mail had been returned to ALSPAC within the
last two years (2011/2012). In a few cases, ALSPAC had
received returned mail more than ten years previously
(a maximum of 14 years in both arms of the trial) or the
date of returned mail was not recorded. Of the 150 par-
ticipants in each arm of the trial, the address found
through office-based tracking matched the last known
address for 24 participants in the opt-in arm and 22 par-
ticipants in the opt-out arm (24/150 = 16 % v 22/150 =
15 %; p = 0.87). Following randomisation, five cases in
the opt-in arm and eleven cases in the opt-out arm of the
trial were withdrawn as they had since made contact with
ALSPAC or were identified as being non-contactable due
to family or health problems. Therefore, a total of 284
invitation letters were sent to participants - 145 opt-in
(57 mothers and 88 YPs) and 139 opt-out (58 mothers
and 81 YPs). The numbers and percentages for whom the
letter was returned to sender (indicating our address
searching had been unsuccessful) was similar in both
groups (12/145 = 8 % in the opt-in arm v 14/139 = 10 % in
the opt-out arm; p = 0.68). In the opt-in arm, three partici-
pants opted in to a home visit (one mother and two YPs)
and no participants opted out in the opt-out arm, leaving
142 participants in total eligible for a home visit. In
addition, 12 participants in the opt-in arm, for whom the
invitation letter was returned to sender, were referred to a
fieldworker for a home visit (Table 2). These are analysed
in the opt-in arm on an intention to treat basis, but some
analyses are repeated having removed these participants
from the opt-in arm, since they had not opted in and
therefore should not have received a home visit.
Table 2 Numbers of participants sent an invitation letter,
number for whom the letter was returned to sender, and the
numbers of participants referred to a fieldworker for a home visit
(the number and percentage in each arm are shown)
Number of participants sent an
invitation letter
Opt-in
N = 145
Opt-out
N = 139
Returned to sender 12 (8 %) 14 (10 %)
Opted-in 3 (2 %) N/A
Referred for home visit 15 (10 %)a 139 (100 %)
aWould have been 3 (2 %) if ‘returned to sender’ not included
Fig. 1 Participant flow diagram for the randomised controlled trial showing t
from those eligible, random allocation to the opt-in and opt-out arms of
opted in or out in each arm. It also shows outcomes in each arm of the trial -
consented to data linkage (YPs only)
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Fig. 1. The main outcomes are whether the participant
was successfully traced and whether they consented to
continue in the ALSPAC study. The proportion who
were traced was much higher in the opt-out arm (77/
150 = 51 %) than the opt-in arm (6/150 = 4 %, 95 %
confidence interval for difference (38 %, 58 %)), and
similarly for the proportion who consented to continue
in ALSPAC (46/150 = 31 % v 4/150 = 3 %, 95 % confi-
dence interval for difference (20 %, 36 %)). Of those
who consented in the opt-out arm, 21 were mothers
and 24 were YPs. This equates to a success rate of 35 %he number of eligible participants, random selection of participants
the trial, numbers withdrawn after randomisation, and numbers who
numbers traced, who consented to continue in ALSPAC, and who
Table 4 For YPs only: Number who consented to participate in
ALSPAC and outcomes regarding consent for data linkage, for
opt-in and opt-out arms of the trial (the number and percentage in
each arm are shown)
Number of YPs who consented to
participate in ALSPAC
Opt-in
N = 3
Opt-out
N = 24a
Data linkage discussed 3 (100 %) 22 (92 %)
Consent to at least one type of data linkageb 3 (100 %) 22 (92 %)
Consent to any data linkage refused 0 (0 %) 0 (0 %)
aExcluding the participant who gave consent by telephone
bLinkage to the following routine records: Health, School, Higher Education,
Benefits, Earnings and Employment, Criminal Convictions and Cautions
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of a difference; p = 0.28).
We were also interested in whether participants in the
opt-in arm were more likely to consent, given that they had
been referred to a fieldworker for a home visit (see Table 3).
On an intention-to-treat basis, there was no evidence of a
difference in this outcome between the two arms (4/15 =
27 % in the opt-in arm v 46/139 = 33 % in the opt-out arm).
If, however, only those who had opted in were included in
the opt-in arm, then there was some evidence that partici-
pants visited in the opt-in arm were more likely to enter
into a discussion with the fieldworker (3/3 = 100 % v 54/
139 = 39 %) and more likely to consent to continue in the
study (3/3 = 100 % v 46/139 = 33 %).
A secondary outcome was consent to data linkage
(for the YPs only). The numbers of YPs consenting to con-
tinuing in the study, and the number of these who also con-
sented to data linkage (with at least one of the routine data
sources listed in the Methods section above), are shown in
Table 4. In only two cases in the opt-out arm (none in the
opt-in arm) did the fieldworker feel it was inappropriate to
discuss data linkage with the participant, and all partici-
pants approached about data linkage consented to at least
one form of data linkage (3 opt-in, 22 opt-out). There was a
difference between the proportions of YPs who consented
to data linkage in the opt-in arm compared with the opt-
out arm (3/150 = 2 % v 22/150 = 15 %; 95 % confidence
interval for difference (-7 %,-19 %)). However, of those YPs
who consented to continue in ALSPAC (3 opt-in, 24 opt-
out), there was no evidence of a difference between the two
trial arms in the likelihood of going on to consent to some
form of data linkage (100 % v 92 %; p = 0.8).
Characteristics of consented participants
It is also of interest to consider the effect of the opt-out
approach on the representativeness of the consented
participants e.g. in terms of mother/YP status and gen-
der. Participation rates are generally higher amongst
mothers than YPs, and for YPs they are higher for fe-
males than males [3, 4]. Based on the original rando-
mised sample, we found that the success rate of the
opt-out approach in tracing participants was higher for
mothers (53 %) than YPs (40 %) but that the consentTable 3 Outcomes of attempted home visits, for opt-in and
opt-out arms of the trial (the number and percentage in each
arm are shown)
Number of participants referred
to interviewer for home visit
Opt-in N = 15 Opt-out N = 139
Participant traceable 6 (40 %)a 77 (55 %)
Discussion took place 4 (27 %)a 54 (39 %)
Consent to ALSPAC given 4 (27 %)a 46b(33 %)
aWould have been 3 (100 %) if ‘returned to sender’ not included
bIncludes one participant who preferred to give consent by telephonerate in the opt-out arm was similar amongst mothers
(30 %) and male YPs (32 %) but lower among female
YPs (20 %). Also of interest is the previous participation
history of those who consented, since those for whom
we already hold research data will contribute more to
future analyses. For YPs, we found that those who con-
sented had on average a higher previous participation
score than those who did not (Wilcoxen rank-sum test,
p = 0.05).Cost-effectiveness
The mean cost per participant was £8.14 in the opt-in
arm and £71.93 in the opt-out arm (see Table 5). The
cost of the fieldworker for the home visits made up the
majority of these costs - £5.13 and £54.60 respectively.
In terms of total costs, it cost an extra £8818.87 in the
opt-out arm to consent 42 more people than the opt-in
arm, an incremental cost-effectiveness ratio of £209.97
per additional participant consented.Acceptability
In general there was little question over the acceptability
of Ipsos MORI contacting the participants, despite some
participants not remembering that they had previously
been involved in the study. Fieldworkers reported that,
on receiving the advance mailing, participants were
more likely to question the relevance of the study to
their current lives than the acceptability of the approach
(opt-in or opt-out). Comparing the two arms of the trial,
it appeared that the opt-out approach was as acceptable
to participants as the opt-in approach. No participants
queried or commented specifically on the opt-in or opt-
out approach. When questioned directly about it, a few
participants raised concerns about the acceptability of
being re-contacted after a significant amount of time.
Specific concerns were around how Ipsos MORI had
obtained their contact details, and being visited without
prior warning (for those who had missed the advance
letter).
Table 5 Mean resource use, cost and total cost per participant and overall total cost
Mean resource use per participant Mean cost per participant (£)
Resource Opt-in N = 145 Opt-out N = 139 Unit cost (£) Opt-in N = 145 Opt-out N = 139
Travel per visit (number of visits) 0.34 3.60 2.05 0.69 7.36
Attempted and actual home visits (number of visits)) 0.34 3.60 15.18b 5.13 54.60
Telephone calls-landline and mobile (number of calls) 0.28 1.29 6.00a 1.70 7.77
Other contact (number of contacts)) 0.10 0.37 6.00a 0.62 2.20
Total mean cost per participant 8.14 71.93
Total cost 1180.07 9998.93
Number of participants who consented 4 46
aThese unit costs were based on an assumption of each telephone call/other contact lasting 10 min, using the MORI cost per hour of a fieldworker of £36
bIpsos MORI were only able to give a total cost of fieldwork (£8,600). In order to obtain the unit cost, the cost of the telephone calls and other contacts were
subtracted from this cost, prior to being divided by the total number of events in the study
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pants who completed an interview with a fieldworker.
All 49 of these participants felt that it was acceptable
(78 % ‘totally acceptable’, 22 % ‘mainly acceptable’).
Among the four in the opt-in arm, three said that the in-
formation/explanation was good, and two said that they
liked the chance to ask questions, found it easy/conveni-
ent, liked meeting someone face-to-face and generally
felt more interested in taking part in the future. Similar
responses were obtained from the 45 opt-out partici-
pants, but they were most likely to say that it was good
to meet someone face-to-face or that the information/
explanation was good. Some said that they did not re-
ceive or remember receiving an advance letter. Other
feedback included that using home visits for engagement
is effective, and more direct than simply sending a letter.
Participants felt that using fieldworkers to visit them in
their home demonstrated that ALSPAC values their par-
ticipation, and they found it convenient.
On the whole, YPs found the data linkage materials
user-friendly and were happy to discuss this consent.
The conversation took place in 25 out of the 27 face-to-
face interviews where the participant had consented to
continue in ALSPAC. All 25 of those approached about
data linkage said the process was acceptable, with 23
(92 %) saying it was very acceptable. None of those with
whom it was discussed refused access to their health or
educational (including school, higher and further educa-
tion) records, suggesting that these are the most accept-
able types of data linkage for YPs. Feedback from
interviewers indicated that data linkage in relation to
benefits and earnings was the most problematic element
and was often questioned by participants.
Where neighbours were approached to help with tra-
cing, their response was also recorded as either ‘gener-
ally positive’, ‘generally neutral’ or ‘generally negative’.
The ALSPAC Ethics and Law Committee assessed the
acceptability of contacting neighbours and community
members after 20 such individuals had been contacted,and approved the continuation of the trial (based on
70 % positive and 30 % neutral response). By the end of
the study, a total of 69 neighbours had been contacted
and of these 58 % were ‘generally positive’, 32 % were
‘generally neutral’ and 10 % were ‘generally negative’.
There was no evidence of a difference between the opt-
in and opt-out arms (p = 0.4). Other community mem-
bers were also generally helpful and happy to be asked
for information, though they often did not know the
current whereabouts of the participant. Very few neigh-
bours or community members were able or willing to
provide full addresses. They were more willing to give
telephone numbers or pass on tracing letters to the
participants.
Discussion
Main findings
This randomised controlled trial has confirmed that an
opt-out approach to home visits is more effective than an
opt-in approach in tracing participants, gaining their con-
sent to store contact details for future invitations to partici-
pate, and (for the YPs only) gaining consent to data linkage,
however, this has to be balanced against the increased cost
of the opt-out approach. It has also confirmed that partici-
pants who actively opt to receive a home visit are more
willing to enter into a discussion with the fieldworker when
they visit, and the visit is more likely to result in the partici-
pant consenting to continue in the study, but also that the
absolute number of consents achieved with this approach
was negligible (3 % of those invited to take part).
Although an equivalent trial has not previously been
published, our findings concur with those of a similar
experiment which evaluated the effectiveness of encour-
aging participants in a longitudinal study to contact the
interviewer to book an appointment [30]. They found
that fewer interviewer calls were needed for those partic-
ipants who took up the offer, but that relatively few par-
ticipants did so (7 % with no incentive, 11 % with an
incentive). These figures are nevertheless higher than
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could in part be explained by the high proportion of let-
ters which were ‘returned to sender’.
As well as effectiveness and cost-effectiveness, another
key outcome of the trial was the acceptability of the two
approaches to participants, neighbours and community
members who were contacted during the tracing process.
Feedback from participants did not indicate any difference
in the acceptability of the two methods from their point of
view. This agrees with findings of research with US veterans
comparing opt-in and opt-out approaches to medical re-
search. The majority did not strongly favour one model
over another [31]. Neighbours and community members
were generally positive when approached by fieldworkers,
although fieldworkers reported that it would have helped if
they had been able to mention the study by name.
Recommendations for future tracing
It seems clear that the opt-out approach is acceptable and
more effective for gaining consent to participation than
the opt-in approach. In this trial it succeeded in tracing
53 % of mothers and 40 % of YPs (similar for males and
females), and resulted in consent rates of about 30 % for
mothers and male YPs, though somewhat lower for female
YPs (20 %). The greater success in tracing mothers was to
be expected, given that YPs are a more mobile cohort, but
it is not clear why the proportion of those traced who go
on to give consent is higher for male YPs than female YPs.
If adopted for future engagement work, there are several
ways in which it could be made more cost-effective than in
this study. Firstly, we only included ‘disengaged’ partici-
pants, who had not participated in the last 5 years. It is
likely that home visits would be more successful for more
recently engaged participants, but also that other methods
of confirming addresses (phone/letter) would be more cost-
effective for these participants. Further work is required to
assess the success and cost-effectiveness of different
methods of confirming addresses in different subgroups of
‘lost’ participants (those for whom mail has been returned
to sender, indicating that the address we hold is out of
date). Recent work by the UK Millennium Cohort Study
has assessed how respondent characteristics which predict
the success of office- and field-based tracking might be
used to tailor tracking techniques for specific groups of par-
ticipants [18].
Secondly, Ipsos MORI reported that only 45 % of the
sample they attempted to visit were confirmed as living at
address provided by ALSPAC. More thorough desk-based
tracking before issuing addresses to fieldworkers would im-
prove the cost-effectiveness of the fieldwork, particularly
for a mobile cohort such as the ALSPAC YPs, and for other
cohorts with a similarly long interval between data collec-
tion exercises. It would reduce the proportion of partici-
pants who received a home visit without receiving anadvance letter, which was an issue that some participants
raised as a concern. As expected, addresses provided were
slightly more accurate for mothers than YPs, who tend to
be more mobile. Using social media sites such as Facebook
and LinkedIn may improve office-based tracking for YPs
since, while many young people are transient in terms of
their address, they tend to have a more consistent social
media presence. Although online resources [32], and more
specifically social networks [33, 34], have already been used
for tracing participants in longitudinal studies with rela-
tively successful results, there are acceptability issues to
consider here as there is no history of ALSPAC contacting
participants in this way.
Thirdly, if the home-visit approach was rolled out to a
larger number of participants, then it would clearly be-
come more cost-effective as the addresses to be visited
could be more efficiently clustered, cutting down on travel
time for the interviewers.
Fourthly, allowing more time for fieldwork than was pos-
sible in the study reported here would increase the chances
of success. Finally, being able to mention ALSPAC to family
or neighbours when conducting in-field tracing would in-
crease their willingness to provide information. Although
the policy of not mentioning ALSPAC or University of the
Bristol was put in place to protect the participants from
information about their participation being disclosed,
fieldworkers found that in practice, withholding this infor-
mation generated more suspicion than being open about
the purpose of the visit. Consideration by ethics commit-
tees of the possible negative consequences of this disclos-
ure balanced against the likely positive benefits to society
in terms of more effective tracing may enable a more open
approach to be used in future tracing activities.
Generalisability
The findings presented here in relation to the effectiveness
and acceptability of the opt-in and opt-out approaches to
home visits can be generalised to other longitudinal stud-
ies, particularly those which, like ALSPAC, have been run-
ning for a considerable number of years leading to
attrition and, in some cases, many years of disengagement
with the study. It seems likely that the best methods of
tracing disengaged participants depend on the age of the
cohort. For example, for a cohort of younger children, tra-
cing through schools may be more successful than search-
ing for residential addresses. However, we have shown
that the opt-out approach to home visits was successful in
two generations of participants, gaining consent from
27 % of randomised YPs (around 21 years of age) and
35 % of mothers who were randomised (who have a
broader age range in their 40s and 50s). If only those who
received letters of invitation are considered, success rates
increase to 30 % and 38 % respectively. Due to the mobil-
ity of the younger generation, we might predict that the
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crease for the ages between these two generations. We
found no evidence that this approach would widen any
existing gender imbalance in the consented sample by
recruiting more female YPs than male YPs.
Calderwood [17] has suggested that using interviewers
for tracking without data collection is effective in
geographically-based studies. ALSPAC is a regionally-
defined birth cohort study, so home visits are more
viable than in other cohort studies which are not geo-
graphically based. Furthermore, this trial was restricted
to those participants thought (based on desk-based ad-
dress searching) to be still living in the Bristol area. The
cost-effectiveness of the approach trialed here is likely
to decrease if a wider geographical area is included.
Conversely, the cost-effectiveness of both approaches
(opt-in and opt-out) is likely to increase if larger sam-
ples were referred for home visits. It is not known
whether our findings for opt-in versus opt-out home
visits for the purposes of tracing lost participants are
also applicable to home visits in prospective cohort
studies which aim to collect questionnaire data or bio-
samples. While acceptability of the approach trialed in
this study was generally high, the feedback from field-
workers that participants seemed relieved when they
realised they were not being asked to do more than con-
sent to their updated details being held on the study
database suggests that this approach may be less accept-
able if used for data collection.Limitations
A major limitation of this study was the quality of the
address data supplied to the fieldworkers. As well as
affecting the effectiveness of the home visits, as field-
workers spent much of their time tracing participants,
it also affected the cost-effectiveness, since more reli-
able address information would enable more cost-
effective fieldwork. The analysis of cost-effectiveness
was based on the assumption that visits in each arm
cost the same in terms of fieldworker time and travel
expenses. In reality, this assumption is not likely to
hold for fieldworker time. For example, we might ex-
pect visits in the opt-in arm to take longer because an
attempted home visit was more likely to be successful
(in which case we have over-estimated the difference in
costs of the two approaches), or conversely visits in the
opt-out arm might take longer because of more time
spent on tracing e.g. visiting neighbours (in which case
the difference in costs is greater than we have
estimated).
As this was viewed as a pilot, it was on a fairly small
scale, with just 154 addresses being issued to fieldwor-
kers. As noted above, this approach will be more cost-effective in geographically based longitudinal studies,
and in the areas with the greatest concentration of par-
ticipants (e.g. urban centres rather than rural areas).
Another limitation of this study is the scope of the out-
comes. We have focused on proximal outcomes such as
successful tracing and consent to hold contact details. It
would also be important to look in more detail at the
demographic profile of those who consented as a result of
the trial and consider to what extent they improve the
representativeness of current participants and, based on
the amount of research data we hold for them, how much
they will contribute to future research analyses.
Conclusions
This trial has shown that an opt-out approach is more ef-
fective in tracing lost participants in a large population-
based cohort study than an opt-in approach, and that a
good proportion of participants traced using this approach
are willing to be part of the cohort. The opt-out approach
is more intensive in terms of fieldworker time than the
opt-in approach and therefore the extra costs involved
with this approach have to be taken into account when
considering which approach to use. Total mean costs per
participant were estimated at £8.14 per participant in the
opt-in arm, and £71.93 per participant in the opt-out arm,
and it was estimated that it cost an extra £209.97 per add-
itional participant consented in the opt-out arm. Our find-
ings suggest that studies such as ALSPAC, which rely on
postal addresses for data collection, may be substantially
improved by investment in an opt-out tracking and tra-
cing approach to re-engage participants. The resulting
gains in the numbers of consenting participants would im-
prove overall sample size and the indications are that it
would not exacerbate bias in the sample, although further
work is needed to look at the long-term outcomes in
terms of data collection from re-engaged participants.
Additional file
Additional file 1: Supplementary Table S1. Description of data: The
key tracing steps in order of priority.
Abbreviations
ALSPAC: Avon Longitudinal Study of Parents and Children; ICER: Incremental
Cost-Effectiveness Ratio; RCT: Randomised Controlled Trial; YP: Young Person/
People.
Competing interests
The authors declare that they have no competing interests.
Author’s contributions
LB initiated the study. All authors contributed to the design of the study. AB
and JM developed the YP linkage consent materials. IB, JM, RR and PH
contributed to the execution of the study. RW and KB were responsible for
the fieldwork elements. IB performed the statistical analysis and wrote the
first draft of the paper. SN performed the economic analysis. KT oversaw the
statistical analysis and writing-up of the study. All authors read and approved
the final manuscript.
Bray et al. BMC Medical Research Methodology  (2015) 15:52 Page 11 of 11Acknowledgements
We are extremely grateful to all the families who took part in this study, the
midwives for their help in recruiting them, and the whole ALSPAC team,
which includes interviewers, computer and laboratory technicians, clerical
workers, research scientists, volunteers, managers, receptionists and nurses.Funding
The UK Medical Research Council (MRC), the Wellcome Trust and the
University of Bristol currently provide core funding support for ALSPAC
(MRC/Wellcome Trust code 102215/Z/13/Z). Data collection is funded from a
wide range of sources which are detailed on the ALSPAC website: http://
www.bristol.ac.uk/alspac/participants/ethics/funding/.
Author details
1Department of Health and Social Science, University of the West of England,
Frenchay Campus, Bristol BS16 1QY, UK. 2School of Social and Community
Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8
2PS, UK. 3ALSPAC, School of Social and Community Medicine, University of
Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK. 4The Ethox
Centre, Nuffield Department of Population Health, University of Oxford, Old
Road Campus, Oxford OX3 7LF, UK. 5Ipsos MORI, 79-81 Borough Road,
London SE1 1FY, UK.
Received: 19 December 2014 Accepted: 3 June 2015
References
1. Pirus C, Leridon H. Large cohort studies across the world. Population-E.
2010;65:575–630.
2. Ketende SC, McDonald J, Dex S. Non-response in the 1970 British Cohort
Study (BCS70) from birth to 34 years., CLS Cohort Studies Working Paper.
2010. Centre for Longitudinal Studies.
3. Boyd A, Golding J, Macleod J, Lawlor D, Fraser A, Henderson J, et al. Cohort Profile:
the ‘children of the 90s’ - the index offspring of the Avon longitudinal study of
parents and children. Int J Epidemiology. 2013;42:111–27.
4. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Ness A, et al.
Cohort profile: the Avon longitudinal study of parents and children: ALSPAC
mothers cohort. Int J Epidemiology. 2013;42:97–110.
5. Goncalves H, Assuncao MCF, Wehrmeister FC, Oliveira IO, Barros FC, Victora
CG, et al. Cohort profile update: The 1993 Pelotas (Brazil) birth cohort
follow-up visits in adolescence. Int J Epidemiology. 2014;43:1082–8.
6. Connelly R, Platt L. Cohort profile: UK Millennium Cohort Study (MCS). Int
J Epidemiology. 2014;43:1719–25.
7. Winding TN, Andersen JH, Labriola M, Nohr EA. Initial non-participation and
loss to follow-up in a Danish youth cohort: implications for relative risk
estimates. J Epidemiol Community Health. 2014;68:137–44.
8. Johnson S, Seaton SE, Manktelow BN, Smith LK, Field D, Draper ES, et al.
Telephone interviews and online questionnaires can be used to improve
neurodevelopmental follow-up rates. BMC Res Notes. 2014;7:219.
9. Bracken MB, Baker D, Cauley JA, Chambers C, Culhane J, Dabelea D, et al.
New models for large prospective studies: is there a risk of throwing out
the baby with the bathwater? Am J Epidemiology. 2013;177:285–9.
10. Howe LD, Galobardes B, Tilling K, Lawlor DA. Does drop-out from cohort
studies bias estimates of socio-economic inequalities in health? J Epidemiol
Community Health. 2011;65 Suppl 1:A31.
11. Howe LD, Tilling K, Galobardes B, Lawlor DA. Loss to follow-up in cohort
studies: bias in estimates of socio-economic inequalities. Epidemiology.
2013;24:1–9.
12. Kramer MS, Wilkins R, Goulet L, Séguin L, Lydon J, Kahn SR, et al. Montreal
prematurity study group: Investigating socio-economic disparities in
preterm birth: evidence for selective study participation and selection bias.
Paediatr Perinat Epidemiol. 2009;23:301–9.
13. Nohr EA, Olsen J. Commentary: Epidemiologists have debated representativeness
for more than 40 years—has the time come to move on? Int J Epidemiol.
2013;42:1016–7.
14. Lepkowski JM, Couper MP. Nonresponse in longitudinal household surveys.
In: Groves RM, Dillman D, Eltinge J, Little R, editors. Survey Nonresponse.
New York: Wiley; 2001. p. 259–72.
15. Ribisl KM, Walton MA, Mowbray CT, Luke DA, Davidson WS, Bootsmiller BJ.
J:Minimizing participant attrition in panel studies through the use ofeffective retention and tracking strategies: review and recommendations.
Eval Program Plann. 1996;19:1–25.
16. Hunt JR, White E. Retaining and tracking cohort study members. Epidemiol
Rev. 1998;20:57–70.
17. Calderwood L. The role of respondent characteristics in tracking on
longitudinal surveys: evidence from the UK Millenium Cohort Study.
Longitudinal and Life course Studies. 2013;4:105–18.
18. Fumagalli L, Laurie H, Lynn P. Experiments with methods to reduce attrition
in longitudinal surveys. J R Statist Soc A. 2013;176:499–519.
19. McGonagle KA, Schoeni RF, Couper MP, Mushtaq M. An incentive
experiment designed to increase response to a between-wave contact
update mailing in two panel studies. Surv Pract. 2011;4.
20. McGonagle KA, Schoeni RF, Couper MP. The effects of a between-wave
incentive experiment on contact update and production outcomes in a
panel study. J Off Stat. 2013;29:261–76.
21. Couper MP, Ofstedal MB. Keeping in contact with mobile sample members. In:
Lynn P, editor. Methodology of Longitudinal Surveys. Chichester (UK): Wiley;
2009. p. 183–203.
22. Dunn KM, Jordan K, Lacey RJ, Shapley M, Jinks C. Patterns of consent in
epidemiologic research: Evidence from over 25,000 responders.
AmJEpidemiol. 2004;159:1087–94.
23. Hunt KJ, Shlomo N, Addington-Hall J. Participant recruitment in sensitive
surveys: a comparison trial of ‘opt in’ versus ‘opt out’ approaches. BMC Med
Res Method. 2013;13:3.
24. Lacy K, Kremer P, de Silva-Sanigorski A, Allender S, Leslie E, Jones L, et al.
The appropriateness of opt-out consent for monitoring childhood obesity
in Australia. PediatrObes. 2012;7:e62–7.
25. Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstrøm M, Johansen M, et al.
Strategies to improve recruitment to randomised controlled trials. Cochrane
Database Syst Rev. 2010;4, MR000013.
26. Junghans C, Feder G, Hemingway H, Timmis A, Jones M. Recruiting patients
to medical research: double blind randomised trial of “opt-in” versus
“opt-out” strategies. BMJ. 2005;331:940.
27. ALSPAC Data Dictionary [http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary]
28. StataCorp. Stata Statistical Software: Release 12. College Station, TX:
StataCorp L; 2011.
29. Calderwood L. Tracking sample members in longitudinal studies. Survey
Practice. 2012;5.
30. Brown M, Calderwood L. Can encouraging respondents to contact
interviewers to make appointments boost co-operation rates and save
costs? Evidence from a randomised experiment in the UK, Centre for
Longitudinal Studies. 2013. Working Paper 2013/9.
31. Kaufman D, Bollinger J, Dvoskin R, Scott J. Preferences for opt-in and
opt—out enrolment and consent models in biobank research: a national
survey of Veterans Administration patients. Genet Med. 2012;14:787–94.
32. Williams IL, O’Donnell CR. Web-based tracking methods in longitudinal
studies. Eval Program Plann. 2014;45:82–9.
33. Mychasiuk R, Benzies K. Facebook: an effective tool for participant retention
in longitudinal research. Child Care Health Dev. 2012;38:753–6.
34. Bolanas F, Herbeck D, Christou D, Lovinger K, Pham A, Raihan A, et al. Using
Facebook to maximise follow-up response rates in a longitudinal study of
adults who use methamphetamine. Subst Abuse Res Treat. 2012;6:1–11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
